MECASERMIN for Growth retardation: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where MECASERMIN was used for Growth retardation.
Most Reported Side Effects for MECASERMIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 117 | 24.6% | 2 | 23 |
| Headache | 41 | 8.6% | 0 | 4 |
| Hypoglycaemia | 36 | 7.6% | 0 | 17 |
| Blood glucose decreased | 32 | 6.7% | 0 | 0 |
| Drug dose omission | 27 | 5.7% | 0 | 5 |
| Injection site pain | 26 | 5.5% | 0 | 0 |
| Vomiting | 26 | 5.5% | 0 | 5 |
| Fatigue | 25 | 5.3% | 0 | 2 |
| Pyrexia | 23 | 4.8% | 0 | 1 |
| Decreased appetite | 22 | 4.6% | 0 | 5 |
| Product dose omission issue | 22 | 4.6% | 0 | 2 |
| Tonsillar hypertrophy | 22 | 4.6% | 0 | 7 |
| Drug ineffective | 21 | 4.4% | 0 | 1 |
| Malaise | 20 | 4.2% | 0 | 3 |
| Inappropriate schedule of drug administration | 14 | 2.9% | 0 | 1 |
Other Indications for MECASERMIN
Primary insulin like growth factor-1 deficiency (143)
Off label use (112)
Body height below normal (82)
Product use in unapproved indication (55)
Insulin-like growth factor decreased (44)
Product used for unknown indication (38)
Growth failure (29)
Short stature (29)
Growth hormone deficiency (28)
Severe primary insulin like growth factor-1 deficiency (20)